Business
New Study: RenovaCare SkinGun™ Ultra-Gently Sprays Human Stem Cells to Achieve ‘Gold-Standard’ Viability for Skin Regeneration
New Study: RenovaCare SkinGun™ Ultra-Gently Sprays Human Stem Cells to Achieve ‘Gold-Standard’ Viability for Skin Regeneration.
About this update from Renovacare, Inc.
[{"type":"text","content":"\n \n RenovaCare, Inc., (OTCQB:RCAR), a developer of novel medical grade \n liquid spray devices and patented CellMist™ and SkinGun™ technologies*, \n today announced favorable outcomes from laboratory studies conducted by \n Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a \n translational research center at Charité – Universitätsmedizin Berlin, \n one of the world’s largest university hospitals.\n \n\nThis Smart News Release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20160503005131/en/\n\n \n \n RenovaCare SkinGun™ ultra-gently sprays patient's own stem cells for burns and wounds (Contributed photo: RenovaCare, Inc.) \n\n\n \n “Our goal is to work towards the use of our CellMist™ and SkinGun™ \n technologies to quickly isolate a patient’s own stem cells and gently \n spray them onto burns and wounds for rapid self-healing,” said Thomas \n Bold, President and CEO of RenovaCare, Inc. “Today’s study results \n provide pre-clinical support for our methodology for first isolating \n keratinocytes from skin samples, and subsequently achieving even and \n gentle spray application without harming these powerful yet delicate \n cells.”\n \n \n Charité scientists presented their findings from in vitro studies \n at the EPUAP Focus Meeting 2016 in Berlin, Germany. Data demonstrated \n that human skin stem cells sprayed with the company’s patented SkinGun™ \n device maintained 97.3% viability. Cell viability is essential to \n regenerating skin for burns, wounds, and cosmetic applications. Cell \n growth was comparable to pipetting, the industry’s widely accepted \n ‘gold-standard’ for the deposition of cells.\n \n \n “The results show that the described method consistently allows \n isolating keratinocytes with characteristics suitable for therapeutic \n applications. This indicates that use of the SkinGun™ for spray \n application of keratinocytes may allow for even distribution of cells \n with no impairment of cell viability or cell growth when evaluated in \n vitro, in contrast to those evaluations with conventionally seeded \n cells,” concluded study authors, Dr. Christa Johnen, Nadja Strahl, and \n Dr. Katrin Zeilinger.\n \n \n Among ...